You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

On 9th February 2019, the European Union Falsified Medicines Directive (EU FMD) will come into force. The Directive introduces measures to combat falsified medicines.

These measures will comprise of an Anti-tamper device, and a 2D Matrix barcode which dispensers will need to scan to verify their authenticity before dispensing to patients.

This page has been created for HCPs to support with any queries they may have about these upcoming changes. We will be updating this page as more information becomes available, so please check back regularly.

Further Information